Cargando…

3-Methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate

The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded mol­ecules parallel to the [111] crystallographic direction and by stacking inter­actions between ring...

Descripción completa

Detalles Bibliográficos
Autores principales: Bambagiotti-Alberti, Massimo, Bartolucci, Gianluca, Bruni, Bruno, Coran, Silvia, Di Vaira, Massimo
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2961024/
https://www.ncbi.nlm.nih.gov/pubmed/21202108
http://dx.doi.org/10.1107/S1600536808005308
_version_ 1782188882678251520
author Bambagiotti-Alberti, Massimo
Bartolucci, Gianluca
Bruni, Bruno
Coran, Silvia
Di Vaira, Massimo
author_facet Bambagiotti-Alberti, Massimo
Bartolucci, Gianluca
Bruni, Bruno
Coran, Silvia
Di Vaira, Massimo
author_sort Bambagiotti-Alberti, Massimo
collection PubMed
description The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded mol­ecules parallel to the [111] crystallographic direction and by stacking inter­actions between rings [centroid–centroid distance between quinone rings = 3.684 (3) Å and between amino­benzoate rings = 4.157 (3) Å] along the ribbons.
format Text
id pubmed-2961024
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-29610242010-12-30 3-Methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate Bambagiotti-Alberti, Massimo Bartolucci, Gianluca Bruni, Bruno Coran, Silvia Di Vaira, Massimo Acta Crystallogr Sect E Struct Rep Online Organic Papers The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded mol­ecules parallel to the [111] crystallographic direction and by stacking inter­actions between rings [centroid–centroid distance between quinone rings = 3.684 (3) Å and between amino­benzoate rings = 4.157 (3) Å] along the ribbons. International Union of Crystallography 2008-03-14 /pmc/articles/PMC2961024/ /pubmed/21202108 http://dx.doi.org/10.1107/S1600536808005308 Text en © Bambagiotti-Alberti et al. 2008 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Bambagiotti-Alberti, Massimo
Bartolucci, Gianluca
Bruni, Bruno
Coran, Silvia
Di Vaira, Massimo
3-Methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate
title 3-Methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate
title_full 3-Methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate
title_fullStr 3-Methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate
title_full_unstemmed 3-Methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate
title_short 3-Methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate
title_sort 3-methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2961024/
https://www.ncbi.nlm.nih.gov/pubmed/21202108
http://dx.doi.org/10.1107/S1600536808005308
work_keys_str_mv AT bambagiottialbertimassimo 3methyl14dioxo14dihydronaphthalen2yl4aminobenzoate
AT bartoluccigianluca 3methyl14dioxo14dihydronaphthalen2yl4aminobenzoate
AT brunibruno 3methyl14dioxo14dihydronaphthalen2yl4aminobenzoate
AT coransilvia 3methyl14dioxo14dihydronaphthalen2yl4aminobenzoate
AT divairamassimo 3methyl14dioxo14dihydronaphthalen2yl4aminobenzoate